Report Search Results	As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 41) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 24-Nov-09 New Constructs, LLC N/A EBS: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10     View Abstract 23-Nov-09 Reuters Investment Profile N/A Emergent BioSolutions Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20     View Abstract 22-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 103 $169     View Abstract 22-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 101 $169     View Abstract 21-Nov-09 Standard & Poor's Quantitative Report N/A Emergent BioSolutions 5 $25     View Abstract 20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ARQL , CBST , EBS , ENZ , NABI , PDLI -- DRUGS 3 $4     View Abstract 20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: EMERGENT BIO -- EBS 1 $4     View Abstract 20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of EMERGENT BIOSOLUTIONS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20     View Abstract 16-Nov-09 Rapid Ratings Rapid Ratings EMERGENT BIOSOLUTIONS INC rated sell (2009-11-16) (US$665) 8 $665     View Abstract 15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: EMERGENT BIOSOLUTIONS INC 5 $25     View Abstract Next 20

Brokerage Reports (Showing 1 to 3 of 3) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 7-Nov-09 Thomson StreetEvents N/A EBS - Event Transcript of Emergent Biosolutions Inc conference call, Nov. 05, 2009 / 5:00pm ET 16 $75     View Abstract 6-Nov-09 Caris & Company David Moskowitz EBS-3Q Light on Biothrax Order Timing 9 $25     View Abstract 31-Oct-09 Thomson StreetEvents N/A EBS.VI - Event Transcript of Erste Group Bank AG conference call, Oct. 30, 2009 / 9:30am ET 19 $75     View Abstract

Independent Reports (Showing 1 to 10 of 38) Release Date  Contributor Author Title Pages Price More Info 24-Nov-09 New Constructs, LLC N/A EBS: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract 23-Nov-09 Reuters Investment Profile N/A Emergent BioSolutions Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract 22-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 103 $169 View Abstract 22-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 101 $169 View Abstract 21-Nov-09 Standard & Poor's Quantitative Report N/A Emergent BioSolutions 5 $25 View Abstract 20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ARQL , CBST , EBS , ENZ , NABI , PDLI -- DRUGS 3 $4 View Abstract 20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: EMERGENT BIO -- EBS 1 $4 View Abstract 20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of EMERGENT BIOSOLUTIONS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract 16-Nov-09 Rapid Ratings Rapid Ratings EMERGENT BIOSOLUTIONS INC rated sell (2009-11-16) (US$665) 8 $665 View Abstract 15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: EMERGENT BIOSOLUTIONS INC 5 $25 View Abstract Next 20